Key highlights this week include the announcement of a couple of acquisition agreements as well as pipeline news from …
Biotech company, Biogen Inc.'s BIIB shares were up more than 5% in pre-market trading with the company surpassing earnings expectations by a wide margin. Revenues also surpassed expectations. The company reported second …
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. Biogen (NASDAQ: BIIB) announced that its Board of Directors authorized a program to repurchase up to $5 billion of the …
The earnings cycle is sending some mixed signals for the first time this quarter as three more widely watched stocks …
Yesterday’s rumored M&A interest in Biogen Inc (NASDAQ:BIIB) spiked the stock 10% in a single day. Now that the euphoria has died down, let’s examine what a realistic takeover number might be. With both Merck and Allergan …
Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. But in the past few days of trading, it gave back about one-third of it. Source: Biogen via YouTube Clearly, this is a momentum stock, so it will never give …
Biogen Inc. BIIB Biogen, a well-known name in the multiple sclerosis ... (Read More: What's in the Cards for Novartis This Earnings Season?) Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon …